TD Cowen analysts view Sen. Dan Sullivan’s proposed missile defense legislation as a long-term catalyst for major U.S. defense contractors, with Lockheed Martin (NYSE:LMT), Northrop Grumman (NYSE:NOC) ...

As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scaliaasked CEO David Ricks if the company ...

In a report released today, Jared Levine from TD Cowen maintained a Hold rating on Dayforce Inc (DAY – Research Report), with a price target of ...

TD Cowen analyst Bryan Bergin updated the financial outlook for Cognizant Technology Solutions (NASDAQ:CTSH), increasing the ...

TD Cowen analyst Daniel Brennan maintained a Buy rating on GeneDx Holdings (WGS – Research Report) today and set a price target of $118.00. The ...

Seeing “growth on hiatus,” Mr. Bir reduced his own forecast for 2025 and 2026 “with revisions mainly for longer lease-up ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry Genetics ...

Noting that Ambry is a profitable testing laboratory that generates more than $300 million of revenue annually, the investment bank thinks that the deal will enable TEM to start generating positive ...